Similar articles for PMID: 14871996

Year	Number of Results
1990	3
1992	4
1993	3
1994	4
1995	3
1996	5
1997	5
1998	6
1999	8
2000	3
2001	6
2002	8
2003	4
2004	4
2005	3
2006	1
2007	3
2008	5
2009	2
2010	3
2011	3
2012	1
2013	5
2014	4
2015	2
2016	3
2017	1
2019	2
2020	2
2021	1
2022	5
2023	1
2024	0

1

Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cells.

Hu Y, Krishan A, Nie W, Sridhar KS, Mayer LD, Bally M. Hu Y, et al. Clin Cancer Res. 2004 Feb 1;10(3):1160-9. doi: 10.1158/1078-0432.ccr-1044-3. Clin Cancer Res. 2004. PMID: 14871996

2

Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.

Adjei AA, Charron M, Rowinsky EK, Svingen PA, Miller J, Reid JM, Sebolt-Leopold J, Ames MM, Kaufmann SH. Adjei AA, et al. Clin Cancer Res. 1998 Mar;4(3):683-91. Clin Cancer Res. 1998. PMID: 9533538

3

Antitumor activity of XR5944, a novel and potent topoisomerase poison.

Stewart AJ, Mistry P, Dangerfield W, Bootle D, Baker M, Kofler B, Okiji S, Baguley BC, Denny WA, Charlton PA. Stewart AJ, et al. Anticancer Drugs. 2001 Apr;12(4):359-67. doi: 10.1097/00001813-200104000-00009. Anticancer Drugs. 2001. PMID: 11335793

4

Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response.

Kancherla RR, Nair JS, Ahmed T, Durrani H, Seiter K, Mannancheril A, Tse-Dinh YC. Kancherla RR, et al. Cancer. 2001 Feb 1;91(3):463-71. doi: 10.1002/1097-0142(20010201)91:3<463::aid-cncr1023>3.0.co;2-r. Cancer. 2001. PMID: 11169927 Clinical Trial.

5

A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.

Seiden MV, Ng SW, Supko JG, Ryan DP, Clark JW, Lynch T, Huang KC, Kwiatkowski D, Skarin A, Eder JP Jr. Seiden MV, et al. Clin Cancer Res. 2002 Mar;8(3):691-7. Clin Cancer Res. 2002. PMID: 11895897 Clinical Trial.

6

Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells.

Grem JL, Politi PM, Berg SL, Benchekroun NM, Patel M, Balis FM, Sinha BK, Dahut W, Allegra CJ. Grem JL, et al. Biochem Pharmacol. 1996 Jun 28;51(12):1649-59. doi: 10.1016/0006-2952(96)00130-x. Biochem Pharmacol. 1996. PMID: 8687480

7

A phase I and pharmacologic study of pyrazoloacridine and cisplatin in patients with advanced cancer.

Dees EC, Rowinsky EK, Noe DA, O'Reilly S, Adjei AA, Elza-Brown K, Donehower RC. Dees EC, et al. Invest New Drugs. 2003 Feb;21(1):75-84. doi: 10.1023/a:1022924511602. Invest New Drugs. 2003. PMID: 12795532 Clinical Trial.

8

Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.

Saraiya B, Gounder M, Dutta J, Saleem A, Collazo C, Zimmerman L, Nazar A, Gharibo M, Schaar D, Lin Y, Shih W, Aisner J, Strair RK, Rubin EH. Saraiya B, et al. Anticancer Drugs. 2008 Apr;19(4):411-20. doi: 10.1097/CAD.0b013e3282f5218b. Anticancer Drugs. 2008. PMID: 18454051 Clinical Trial.

9

Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II.

Kruczynski A, Barret JM, Van Hille B, Chansard N, Astruc J, Menon Y, Duchier C, Créancier L, Hill BT. Kruczynski A, et al. Clin Cancer Res. 2004 May 1;10(9):3156-68. doi: 10.1158/1078-0432.ccr-1305-2. Clin Cancer Res. 2004. PMID: 15131057

10

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.

Hammond LA, Eckardt JR, Ganapathi R, Burris HA, Rodriguez GA, Eckhardt SG, Rothenberg ML, Weiss GR, Kuhn JG, Hodges S, Von Hoff DD, Rowinsky EK. Hammond LA, et al. Clin Cancer Res. 1998 Jun;4(6):1459-67. Clin Cancer Res. 1998. PMID: 9626463 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year